Lower riskDrug recall · FDA · Published June 8, 2026
Accord Healthcare recalls Levothyroxine tablets with subpotent drug risk
Accord Healthcare recalls 90-tablet Levothyroxine Sodium 300 mcg bottles due to subpotent drug content. This may not provide proper thyroid hormone levels. Consumers should contact pharmacy for guidance.
“Accord Healthcare recalls Levothyroxine tablets with subpotent drug risk.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/31213-accord-healthcare-recalls-levothyroxine-tablets-with-subpotent-drug-risk. Based on FDA recall #D-0656-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0656-2026%22&limit=1).
The FDA announced on June 8, 2026, that Accord Healthcare is recalling Levothyroxine Sodium Tablets, USP, 300 mcg due to subpotent drug risks. The recall involves 6,432 bottles distributed nationwide.
How to tell if you have it
Brand: Accord Healthcare
Product: Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg)
Packaging: 90 Tablets bottles, Rx only
NDC: 16729-458-15
Lot #: D2401522
Expiration Date: 06/2026
Quantity: 6,432 bottles
The hazard
The recalled Levothyroxine Sodium Tablets are classified as a subpotent drug. The FDA has not reported specific incidents or injuries related to this recall in the provided facts.
Context
GovInfoNow's records show Accord Healthcare, INC. has 16 other recalls on record since December 20, 2016. Other recent recalls of similar products include Major Pharmaceuticals Levothyroxine Tablets Recall (July 13, 2026), Macleods Levothyroxine Tablets Recall (February 26, 2026), and Alvogen Thyro-Tabs 150mcg Tablets Recall (December 31, 2025).
How to tell if you have this one
Check for the product name 'Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles' with NDC 16729-458-15. The lot number D2401522 was manufactured in Raleigh, NC.
Brand
Accord Healthcare
Category
Drug
Based on the official FDA remedy
What to do — step by step
Contact Your Doctor
Talk to your healthcare provider about whether you need a different dose or product.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “US Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 30 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0656-2026 (June 8, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0656-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.